Predictors for Major Wound Complications Following Preoperative Radiotherapy and Surgery for Soft-Tissue Sarcoma of the Extremities and Trunk: Importance of Tumor Proximity to Skin Surface
- 815 Downloads
Preoperative and postoperative RT for the treatment of high-grade soft-tissue sarcoma result in similar local control and overall survival rates, but morbidities differ. Postoperative RT is associated with a higher rate of long-term fibrosis, edema, and joint stiffness. Preoperative RT is associated with higher rates of wound complications. It is important to identify predictors for major wound complications (MWC) and to develop strategies to minimize this outcome. We reviewed our experience to determine predictors for MWC following preoperative radiotherapy (RT) and surgery for soft-tissue sarcoma.
Between January 2006 and May 2011, 103 patients with soft-tissue sarcoma of the extremities and trunk were treated with preoperative RT followed by surgery. MWCs were defined as those requiring operative or prolonged nonoperative management. Fisher’s exact test was used to compare rates. Logistic regression was used for multivariable analysis of factors potentially associated with MWCs.
Median tumor size was 8.4 cm (range 2–25). All patients had wide or radical resections. Wound closures were primary in 70 %, a vascularized flap in 27 %, and split-thickness skin graft (STSG) in 3 %. There were 36 MWCs (35 %). Significant predictors for MWCs on univariate analysis included diabetes, tumors >10 cm, tumors <3 mm from skin surface, and vascularized flap/STSG closure. The same four variables were significant predictors on multivariable analysis.
MWCs following preoperative RT and surgery were common. Tumor proximity to skin surface <3 mm is a previously unreported independent predictor, and further strategies to minimize wound complications are needed.
KeywordsSkin Surface Postoperative Radiation Therapy Intensity Modulate Radiation Therapy Free Flap Preoperative Radiation Therapy
The authors thank Barbara Silver for her editorial assistance.
Conflict of interest
- 1.Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196(3):305–15.PubMedCrossRefGoogle Scholar
- 4.NCCN. National Comprehensive Cancer Network (NCCN): NCCN clinical practice guidelines in oncology: soft tissue sarcoma. Version 1.2011. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
- 5.O’Sullivan B, Davis A, Turcotte R, et al. Five-year results of a randomized phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol. 2004 ASCO Annual Meeting Proceedings 2004;22(14S July 15 Supplement):Abstract 9007.Google Scholar
- 21.Kuklo TR, Temple HT, Owens BD, et al. Preoperative versus postoperative radiation therapy for soft-tissue sarcomas. Am J Orthop (Belle Mead NJ). 2005;34(2):75–80.Google Scholar
- 25.Cox DR. Analysis of binary data. London: Methuen and Co.; 1970.Google Scholar
- 30.Dickie CI, Griffin A, Parent A, et al. Phase II study of preoperative intensity modulated radiation therapy for lower limb soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2010;78(3 Suppl):S84–S85 [abstract #181].Google Scholar